-+ 0.00%
-+ 0.00%
-+ 0.00%

On Sept 3, Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately; On Spet 4 Jason D. Sawyer Appointed As Interim CEO; Paolone Remains Director After Termination

Benzinga·09/09/2025 21:05:52
Listen to the news

-SEC Filing